Clinical Trial

Exoskeleton Training at Home to Assist Participants With Spinal Cord Injuries to Perform Ambulatory Functions.

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to to confirm the safety and performance of the ABLE Daily to perform ambulatory functions in home and community settings for people with spinal cord injury. The experimental period will cover the training period with the ABLE Daily exoskeleton (3 weeks of use at the investigational site with a total of 9 sessions) and the home period (12 weeks of personal use at home and community environments).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-10; most recent amendment 2026-06-01.
Status change: Suspended → Recruiting 2026-06-01
Status change: Recruiting → Suspended 2026-01-26
Trial Details
NCT Number NCT07062575
Lead Sponsor ABLE Human Motion S.L.
Collaborators: Sint Maartenskliniek, Universitat Politècnica de Catalunya
Conditions Spinal Cord Injury
Enrollment 10 participants
Start Date 2025-06-19
Primary Completion 2026-10-30 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-02